Close Menu

NEW YORK (360Dx) – Clinical Genomics and Quest Diagnostics today announced the US Food and Drug Administration cleared InSure One, a fecal immunochemical test, or FIT, designed to detect blood in stool.

Clinical Genomics manufactures InSure FIT tests, including InSure One, which Quest provides to physicians and organized provider groups, including through specialized programs with accountable care organizations across the US. The companies expect the test to be commercially available in early 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.